Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2006-004320-36-IT
EUCTR2006-004320-36-IT
Active, not recruiting
Not Applicable

Intravitreal Bevacizumab (Avastin) for neovascular age-related macular degeneration - ND

AZIENDA OSPEDALIERA SENESE0 sitesMay 3, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsViasual acuity lossMedDRA version: 9.1Level: SOCClassification code 10015919Term: Eye disorders
DrugsVISUDYNE*INFUS 1FL 15MG 10ML

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Viasual acuity loss
Sponsor
AZIENDA OSPEDALIERA SENESE
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 3, 2007
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
AZIENDA OSPEDALIERA SENESE

Eligibility Criteria

Inclusion Criteria

  • •\- neovascular age\-related macular degeneration
  • •\- age \> 55
  • •\- Visual loss \<4/10
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •\- previous ocular infections
  • •\- intravitreal hemoragies

Outcomes

Primary Outcomes

Not specified

Similar Trials

Withdrawn
Phase 3
Intravitreal Bevacizumab for Inflammatory Neovascular MembranesVogt Koyanagi Harada DiseaseSerpiginous ChoroiditisMultifocal Choroiditis
NCT00407121Asociación para Evitar la Ceguera en México
Completed
Not Applicable
Efficacy of PreOperative Bevacizumab for Diabetic Eye DiseaseProliferative Diabetic Retinopathy
NCT01041690Cairo University19
Completed
Not Applicable
Intravitreal Bevacizumab (Avastin) therapy for Proliferative Diabetic Retinopathydiabetic retinopathy.Retinal disorders in diseases classified elsewhere
IRCT138903314232N1Vice chancellor for research; Babol university of medical sciences39
Completed
Not Applicable
Intravitreal bevacizumab(Avastin) for macular edema secondary to uveitis: 1 year results of a prospective pilot studyMacular edema secondary to uveitis.Other specified retinal disorders
IRCT138902113846N1Shiraz University of Medical Sciences30
Recruiting
Not Applicable
Treatment with bevacizumab for ocular vascular lesionsOcular vascular lesions
JPRN-UMIN000020916Keio University, School of Medicine1,000